Last reviewed · How we verify

NCT04987099

Effects of Increased Maternal Choline Intake on Child Cognitive Development

Active, enrolled NA Last updated 2 October 2024
What this trial tests

NA trial testing 550 mg/day Choline in Pregnancy in 40 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline
13 December 2020
Primary endpoint
31 December 2024
31 December 2024

Quick facts

Lead sponsorCornell University
PhaseNA
StatusActive, enrolled
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingquadruple
Primary purposetreatment
Enrollment40
Start date13 December 2020
Primary completion31 December 2024
Estimated completion31 December 2024
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Cornell University

Who can join

Adults 21 to 40, female only, with Pregnancy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to examine cognitive and affective outcomes in the offspring of women supplemented with choline vs. control during pregnancy.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Pregnancy

Currently open trials in the same condition.

Other Cornell University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04987099.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing